The State of Kentucky is considering spending $42 million on researching ibogaine, a powerful psychedelic that has shown promise in treating or even interrupting opiate use disorder.
November 21, 2023
Kentucky’s medical cannabis program won’t go into effect until January 2025, but plans are being made now to ensure a smooth launch.
October 9, 2023
One amendment would fund psychedelic clinical trials, and the other would provide treatment options for military veterans suffering from traumatic brain injury and PTSD.
September 29, 2023
From politicians to patients, many people spoke at a recent public hearing that will influence a panel’s decision to study ibogaine as a treatment for opioid use disorder.
September 20, 2023
The remarks by Jared Polis came at the Psychedelic Science conference in Denver, Colorado.
June 23, 2023
The findings on psychedelics and "critical periods" offer potential to treat a wide range of conditions, such as stroke and deafness.
June 16, 2023
The money helping to further psychedelic research in Kentucky will come from the Opioid Settlement Fund.
June 2, 2023